Contineum Therapeutics Overview
Contineum Therapeutics Target Price
Analysts' 12-month price predictions for CTNM.
Get informed when a big investor buys or sells
+ FollowShare Price
$11.91
Average Target Price
$16.00
34.3% upside
34.3% upside1 analysts in the last 4 months
High: $16 | Low: $16
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-14 | Morgan Stanley | $16 | 34.3% upside |  |
| 2026-01-08 | Morgan Stanley | $14 | 17.5% upside | |
| 2025-11-24 | Robert W. Baird | $14 | 17.5% upside | |
| 2025-11-21 | RBC CapitalBrian Abrahams | $22 | 84.7% upside | |
| 2025-09-25 | Leerink Partners | $20 | 67.9% upside | |
| 2025-03-07 | Robert W. Baird | $16 | 34.3% upside | |
| 2024-10-21 | Robert W. BairdJoel Beatty | $32 | 168.7% upside | |
| 2024-04-30 | RBC CapitalBrian Abrahams | $30 | 151.9% upside | |
| 2024-04-30 | Stifel NicolausPaul Matteis | $29 | 143.5% upside | |